Serial histopathologic assessment of fulminant myocarditis after the first mRNA COVID-19 vaccine dose

Eur Heart J. 2022 May 21;43(20):1995. doi: 10.1093/eurheartj/ehac083.

Authors

Hiroshi Koiwaya¹, Kensaku Nishihira¹, Kansuke Tomozoe¹, Yoshisato Shibata¹

Affiliation

¹ Department of Cardiology, Miyazaki Medical Association Hospital, 1173 Arita, Miyazaki 880-2102, Japan.

PMID: 35178573
DOI: 10.1093/eurheartj/ehac083

No abstract available

MeSH terms

COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Humans
Myocarditis*
RNA, Messenger
Vaccination

Substances

COVID-19 Vaccines
RNA, Messenger